Skip to content

Sniper Elite Model-Or-E3872XX Series

by Maxxim Medical

510(k) K011905

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

52 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK011905 Date28 Aug 2001ClearedStatusActive

Recalls

52 recalls · FDA

    • Terminated Z-0623-2010 FDA Unclassified (pre-2012) initiated 25 Aug 2009

    Some of the guidewires in these two lots have a straight tip (incorrect) rather than an angled tip (correct configuration for that catalog number).

  • 41 recalls, same reason

    • Terminated Z-1272-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1278-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1280-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1297-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1300-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1270-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1284-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1285-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1292-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1290-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1283-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1299-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1304-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1307-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1288-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1296-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1271-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1281-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1295-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1274-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1269-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1303-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1273-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1275-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1277-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1301-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1305-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1294-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1289-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1267-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1293-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1268-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1291-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1276-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1286-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1298-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1302-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1287-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1306-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1282-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009
    • Terminated Z-1279-2009 FDA Unclassified (pre-2012) initiated 26 Feb 2009

    Hydrophilic guidewires have the potential to demonstrate degradation of the Pebax cladding.

  • 10 recalls, same reason

    • Terminated Z-0891-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0883-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0888-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0889-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0885-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0890-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0882-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0886-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0884-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007
    • Terminated Z-0887-2008 FDA Unclassified (pre-2012) initiated 19 Nov 2007

    Degradation -- Hydrophilic guidewires may exhibit degradation of blue Pebax cladding causing particulate to dislodge potentially resulting in embolism.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DQX
Device Class
Class II
Regulation
21 CFR Part 870.1330
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Maxxim Medical

See all devices from Maxxim Medical →